Mirae Asset Global ETFs Holdings’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Buy
258,321
+18,406
+8% +$999K 0.01% 652
2026
Q1
$15M Buy
239,915
+11,013
+5% +$881K 0.02% 548
2025
Q4
$21.8M Sell
228,902
-75,748
-25% -$7.43M 0.03% 432
2025
Q3
$29.7M Sell
304,650
-22,530
-7% -$2.33M 0.05% 357
2025
Q2
$35.1M Sell
327,180
-4,918
-1% -$498K 0.07% 275
2025
Q1
$33.5M Buy
332,098
+10,334
+3% +$1.04M 0.07% 278
2024
Q4
$28.7M Buy
321,764
+18,146
+6% +$1.6M 0.06% 310
2024
Q3
$25.4M Sell
303,618
-2,076
-0.7% -$164K 0.06% 316
2024
Q2
$23.5M Buy
+305,694
New +$22.4M 0.06% 318

Other funds holding BSX

Mirae Asset Global ETFs Holdings's BSX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Boston Scientific (BSX) stake by 7.7% in Q2 2026, buying an estimated $999K and bringing the position to 258,321 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #652.

Mirae Asset Global ETFs Holdings first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $35.1M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 258,321 shares of Boston Scientific worth $11M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 18,406 Boston Scientific shares in Q2 2026, an estimated $999K.
  • Boston Scientific made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #652 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Boston Scientific position peaked at $35.1M in Q2 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.